5-((4S)-2,2-DIMETHYLOXAN-4-YL)-N-METHYL-1-((1S,2S)-2-METHYL-1-(5-OXO-4H-1,2,4-OXADIAZOL-3-YL)CYCLOPROPYL)-N-PHENYLINDOLE-2-CARBOXAMIDE
UNII W9T75RA4P4
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-((4s)-2,2-dimethyloxan-4-yl)-n-methyl-1-((1s,2s)-2-methyl-1-(5-oxo-4h-1,2,4-oxadiazol-3-yl)cyclopropyl)-n-phenylindole-2-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W9T75RA4P4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2212021-82-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H32N4O4 SIYHUHPATYQMMF-YSDGCRRSSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-((4s)-2,2-dimethyloxan-4-yl)-n-methyl-1-((1s,2s)-2-methyl-1-(5-oxo-4h-1,2,4-oxadiazol-3-yl)cyclopropyl)-n-phenylindole-2-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.